InvestDashboard.com



Puma Biotechnology, Inc. (PBYI)



$19.74
52 Week Low
$40.6
2017-04-28 15:46:20 MDT
$73.27
52 Week High

Basic Info

Healthcare
Sector
Biotechnology
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $1,380,000,000Small Cap (Between $200M and $2B)
Analyst Recommendation:1.7Analysts say: Buy+. (1=Strong Buy, 5=Strong Sell)
Beta: 0.32 Low Volatility Stock (beta under 1). Stock will go up less when the market goes up, and go down less when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: -520.90 %
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: 5.56%
% Above 200 DayMA: 3.18%
PBYI Performance 52 Weeks: 13.61%
S&P 500 Performance 52 Weeks: 12.50%
Uptrend is still intact: PBYI is above both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
PBYI outperforming S&P 500 by 1.11% the last 52 Weeks.

Profile


More Valuation

Price To Book: 6.52
OK Value. Low Price to Book means better value. A P/B value of 5 or less is great.
EV to EBITDA: -4.15
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders12.99% 17.28%Held by fewer than average Insiders.
% Held By Institutions95.30% 62.07%Institutional percentage greater than average. Institutional buying and selling can really move stock price.
Short % Of Float52.99% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to EquityN/A 1.08Unknown.
Profit Margin %N/A-00.18%Unknown.
Operating Margin %N/A-05.28%Unknown.
Return on Equity %-132.75%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-70.18%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $N/A $883,096.70Unknown.
Price to Cash 6.54 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Analysts like this stock: 1.7 (1=Strong Buy, 5=Strong Sell)

  2. Stock is Above Short Term 50DMA: 5.56%

  3. Stock is Above Long Term 200DMA: 3.18%

  4. Stock outperforming S&P 500 over last 52 weeks: 1.11%

CONS:
  1. Less than Average 5 Yr Est Growth: -520.90 %

  2. Price to Cash Ratio (6.54) is greater than average. Company has less cash as a percent of price than the average.

  3. Shorted more than average: 52.99%

  4. Return on Equity is negative: -132.75%

  5. Return on Assets is negative: -70.18%


Headlines


Stock Chart


InvestDashboard.com PBYI: Puma Biotechnology, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.